Kennedy Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-52,776
Closed -$3.64M 764
2024
Q1
$3.64M Sell
52,776
-361,051
-87% -$24.4M 0.07% 395
2023
Q4
$25.8M Buy
413,827
+13,857
+3% +$775K 0.56% 16
2023
Q3
$22.4M Buy
399,970
+170,068
+74% +$9.57M 0.55% 21
2023
Q2
$11.6M Buy
229,902
+109,890
+92% +$5.85M 0.27% 115
2023
Q1
$6.55M Buy
120,012
+3,725
+3% +$218K 0.19% 196
2022
Q4
$7.27M Sell
116,287
-4,068
-3% -$270K 0.21% 165
2022
Q3
$8.48M Sell
120,355
-62,784
-34% -$4.33M 0.25% 125
2022
Q2
$10.4M Sell
183,139
-65,039
-26% -$3.57M 0.29% 107
2022
Q1
$15.5M Buy
248,178
+40,563
+20% +$2.19M 0.37% 63
2021
Q4
$11.6M Buy
207,615
+22,766
+12% +$1.39M 0.25% 134
2021
Q3
$12M Buy
184,849
+30,997
+20% +$2.12M 0.27% 108
2021
Q2
$9.76M Buy
153,852
+87,906
+133% +$5.19M 0.21% 169
2021
Q1
$3.95M Sell
65,946
-6,457
-9% -$351K 0.08% 418
2020
Q4
$3.61M Sell
72,403
-51,050
-41% -$2.4M 0.08% 414
2020
Q3
$6.3M Sell
123,453
-39,274
-24% -$1.64M 0.18% 194
2020
Q2
$5.71M Buy
162,727
+13,563
+9% +$467K 0.17% 222
2020
Q1
$3.79M Sell
149,164
-38,359
-20% -$1.14M 0.14% 278
2019
Q4
$5.2M Buy
+187,523
New +$4.48M 0.13% 315

Other funds holding AXNX

Kennedy Capital Management's AXNX Position: Q2 2024 in Review

Kennedy Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 52,776 shares — an estimated $3.64M sold.

Kennedy Capital Management first reported a position in AXNX in Q4 2019 and held it in 18 quarters. The position peaked at $25.8M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Kennedy Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 52,776 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $3.64M.
  • Kennedy Capital Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
  • Kennedy Capital Management's Axonics, Inc. Common Stock position peaked at $25.8M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Kennedy Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.